The evaluation and treatment of tobacco use disorder.
Okuyemi
K S
KS
Department of Family Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7370, USA. kokuyemi@kumc.edu
Ahluwalia
J S
JS
Wadland
W C
WC
D000465:Algorithms; D016642:Bupropion / Q000191:economics / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003663:Decision Trees; D018765:Dopamine Uptake Inhibitors / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs; D019317:Evidence-Based Medicine; D005194:Family Practice / Q000379:methods*; D015277:Hotlines; D006801:Humans; D007255:Information Services; D020407:Internet; D009538:Nicotine / Q000191:economics / Q000627:therapeutic use; D018722:Nicotinic Agonists / Q000191:economics / Q000627:therapeutic use; D009819:Office Visits; D010353:Patient Education as Topic / Q000379:methods; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods*; D011379:Prognosis; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D016896:Treatment Outcome
D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D016642:Bupropion; D009538:Nicotine